Introduction
The Pitt — Episode 4, discharge update:
"Mr. Gold tested positive for campylobacter and went home on azithromycin." — Doctor
"I hope he loads up on water and electrolytes. The guy filled up half a dozen bedpans." — Dr. Robby
The Mr. Gold scene in The Pitt captures in two lines an extremely common ER situation: severe bacterial gastroenteritis from Campylobacter with an indication for oral antibiotic therapy at discharge. The choice of azithromycin is not accidental — it reflects the most up-to-date protocol for this specific pathogen and for a range of atypical bacterial infections that emergency physicians encounter daily.
Azithromycin belongs to the macrolide class but has unique pharmacokinetic properties that make it especially useful in emergency settings: long half-life, excellent tissue penetration, and simplified dosing that promotes adherence after hospital discharge.
What Is Azithromycin?
Azithromycin is a second-generation macrolide antibiotic, a semi-synthetic derivative of erythromycin, with an expanded spectrum of activity and superior pharmacokinetic profile. Its mechanism of action is inhibition of bacterial protein synthesis through reversible binding to the 50S ribosomal subunit, blocking translocation of the growing peptide chain.
What makes azithromycin unique among macrolides is its tissue concentration pharmacokinetics: it selectively accumulates in inflamed tissues, phagocytes, and macrophages, reaching tissue concentrations 10 to 100 times higher than plasma levels. This allows short treatment regimens — often 3 to 5 days — with efficacy equivalent to or greater than longer-duration antibiotics.
Its plasma half-life is approximately 68 hours, allowing once-daily dosing. This is a significant clinical advantage at hospital discharge, where treatment adherence is always a challenge.
Causes & Clinical Context
In the ER, azithromycin is used across a broad spectrum of infections. The most common indications include:
- Campylobacter jejuni gastroenteritis: the key indication in the episode — the most common cause of bacterial diarrhea worldwide, transmitted through undercooked poultry, contaminated water, and unpasteurized milk
- Mild to moderate community-acquired pneumonia (CAP): coverage of atypical pathogens such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella
- Sexually transmitted infections: Chlamydia trachomatis (single 1g dose), Mycoplasma genitalium
- Pharyngitis and bacterial sinusitis in penicillin-allergic patients
- Mild skin and soft tissue infections in beta-lactam-allergic patients
- Endocarditis prophylaxis for high-risk dental procedures
In The Pitt, Mr. Gold presented with diarrhea voluminous enough to fill several bedpans — a clinical picture suggestive of inflammatory colitis from Campylobacter, not merely secretory gastroenteritis.
Signs & Symptoms
The clinical picture of bacterial gastroenteritis that indicates antibiotic therapy differs from self-limiting viral diarrhea. Signs that guide workup and treatment include:
- Bloody or mucoid diarrhea (dysentery) — strongly suggestive of invasive bacterial etiology
- High fever (>38.5°C / 101.3°F) associated with diarrhea
- Intense abdominal pain with tenesmus
- More than 6 bowel movements in 24 hours with hemodynamic impact
- Signs of severe dehydration: tachycardia, hypotension, dry mucous membranes, oliguria
- Immunocompromised status (HIV, transplant, prolonged corticosteroid use)
- Elderly patients and infants with any febrile diarrhea
Distinguishing traveler's diarrhea, Clostridioides difficile colitis, and Campylobacter infection has direct therapeutic implications — each requires a different antibiotic approach.
Diagnosis
Diagnosis of Campylobacter bacterial gastroenteritis is confirmed by stool culture, which identifies the organism and allows susceptibility testing. In the ER, however, cultures are rarely available at the time of the treatment decision — results take 48 to 72 hours.
The decision to use azithromycin empirically is based on clinical presentation (fever + bloody/mucoid diarrhea), epidemiology (recent poultry consumption, travel, outbreak), and nonspecific lab findings such as leukocytosis, elevated CRP, and fecal leukocytes. In The Pitt, the diagnosis was confirmed before discharge — justifying targeted prescribing.
Emergency Treatment
The treatment protocol for Campylobacter gastroenteritis and other main ER indications for azithromycin follows these guidelines:
- Aggressive hydration: oral rehydration solution (ORS) for mild cases; normal saline IV 20ml/kg bolus for moderate to severe dehydration
- Azithromycin 500mg PO once daily for 3 days for Campylobacter — first-line regimen per CDC and IDSA guidelines
- Azithromycin 500mg on Day 1, then 250mg Days 2–5 for mild to moderate outpatient CAP
- Azithromycin 1g PO single dose for Chlamydia trachomatis
- Discharge instructions: aggressive oral hydration, light diet, return if fever persists after 48h, bloody stools, or clinical deterioration
- Electrolyte replacement: emphasize sodium, potassium, and glucose intake — as Dr. Robby highlighted when stressing hydration and electrolytes
Fluoroquinolones (ciprofloxacin) were historically first-line for Campylobacter, but resistance rates have exceeded 25% in many regions, making azithromycin the preferred agent in current guidelines.
Prognosis & Complications
The vast majority of Campylobacter gastroenteritis cases treated with azithromycin resolve within 5 to 7 days. Prognosis is excellent in immunocompetent patients with access to adequate hydration.
Complications to monitor include:
- Guillain-Barré syndrome: rare but serious complication — C. jejuni infection is the most common infectious trigger of this demyelinating polyneuropathy
- Reactive arthritis (Reiter syndrome): asymmetric large-joint arthritis, uveitis, and urethritis weeks after infection
- QT interval prolongation: important adverse effect of azithromycin — review concomitant medications and cardiac history before prescribing
- Mild hepatotoxicity: transient transaminase elevation, especially at high doses or with prolonged use
- Bacterial resistance: indiscriminate use compromises efficacy in future infections
Frequently Asked Questions
Does every bacterial diarrhea require antibiotics?
No. Most bacterial gastroenteritis is self-limiting and resolves with hydration and supportive care. Antibiotics are indicated in cases with high fever, bloody diarrhea, signs of sepsis, immunocompromised status, or when the identified organism has a specific treatment indication — such as severe Campylobacter infection.
Does azithromycin prolong the QT interval? Is that dangerous?
Yes, azithromycin can modestly prolong the QT interval. The risk of clinically relevant arrhythmia is low in patients without cardiac risk factors, but should be considered in the elderly, patients with pre-existing heart disease, hypokalemia, or those on other QT-prolonging medications. In these cases, alternatives such as doxycycline may be preferable.
What is the difference between azithromycin and other macrolides like erythromycin and clarithromycin?
Azithromycin has a much longer half-life (68h vs 1.5h for erythromycin), enabling once-daily dosing and short regimens. It has fewer drug interactions than clarithromycin (which strongly inhibits CYP3A4) and better gastrointestinal tolerability than erythromycin. For the ER, simplified dosing and good tolerability make azithromycin the preferred macrolide choice.
Is Campylobacter still susceptible to azithromycin?
Azithromycin resistance rates for Campylobacter remain significantly lower than fluoroquinolone resistance in most regions, making it the recommended first-line agent. However, epidemiological surveillance is ongoing — whenever available, susceptibility testing should guide the final antibiotic choice.
Conclusion
Mr. Gold's discharge on azithromycin in The Pitt condenses a clinical decision every emergency physician makes repeatedly: when to treat gastroenteritis with antibiotics and which one to choose. Azithromycin, with its privileged pharmacokinetics, appropriate spectrum for atypical pathogens, and adherence-friendly dosing, is one of the most versatile tools in emergency pharmacology.
Explore related articles in our Emergency Drugs category and the article on Macrolides in Emergency Medicine.
This content is for educational purposes only and does not substitute professional medical evaluation, diagnosis, or treatment. In case of emergency, call 911 immediately.
